PT - JOURNAL ARTICLE AU - Nostaeva, Arina V. AU - Shimansky, Valentin S. AU - Apalko, Svetlana V. AU - Kuznetsov, Ivan A. AU - Sushentseva, Natalya N. AU - Popov, Oleg S. AU - Aulchenko, Yurii S. AU - Shcherbak, Sergey G. TI - Analysis of associations between polygenic risk score and COVID-19 severity in Russian population using low-pass genome sequencing AID - 10.1101/2023.11.20.23298335 DP - 2023 Jan 01 TA - medRxiv PG - 2023.11.20.23298335 4099 - http://medrxiv.org/content/early/2023/11/22/2023.11.20.23298335.short 4100 - http://medrxiv.org/content/early/2023/11/22/2023.11.20.23298335.full AB - The course of COVID-19 is characterized by wide variability, with genetics playing a contributing role. Through large-scale genetic association studies, a significant link between genetic variants and disease severity was established. However, individual genetic variants identified thus far have shown modest effects, indicating a polygenic nature of this trait. To address this, a polygenic risk score (PRS) can be employed to aggregate the effects of multiple single nucleotide polymorphisms (SNPs) into a single number, allowing practical application to individuals within a population. In this work, we investigated the performance of a PRS model in the context of COVID-19 severity in 1085 Russian participants using low-coverage NGS sequencing. By developing a genome-wide PRS model based on summary statistics from the COVID-19 Host Genetics Initiative consortium, we demonstrated that the PRS, which incorporates information from over a million common genetic variants, can effectively identify individuals at significantly higher risk for severe COVID-19. The findings revealed that individuals in the top 10% of the PRS distribution had a markedly elevated risk of severe COVID-19, with an odds ratio (OR) of 2.2 (95% confidence interval (CI): 1.3-3.3, p-value=0.0001). Furthermore, incorporating the PRS into the prediction model significantly improved its accuracy compared to a model that solely relied on demographic information (p-value < 0.0001). This study highlights the potential of PRS as a valuable tool for identifying individuals at increased risk of severe COVID-19 based on their genetic profile.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Saint Petersburg State University, project ID: 94029859.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of The Saint Petersburg State Health Care Establishment the City Hospital No 40 of the Resort District gave ethical approval for this work (protocol number 171, may 18, 2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.